Claire Delbridge

ORCID: 0000-0003-4339-6917 · 1 paper in corpus
2025
·doi:10.20944/preprints202504.1335.v1

Introduction: Glioblastoma (GBM) remains a clinical challenge due to its high recurrence rate and the difficulty of distinguishing true progression from treatment-induced changes. 18-fluoride-fluoro-ethyl-tyrosine positron emission tomogra…